Skip to main content
. Author manuscript; available in PMC: 2024 Jan 23.
Published in final edited form as: Drug Metab Rev. 2020 Jul 9;52(3):333–365. doi: 10.1080/03602532.2020.1772281

Table 1.

Articles covered in this review.

Title Authors Source
Metabolites and drug metabolizing enzymes
1 Metabolism of Strained Rings: Glutathione S-transferase-Catalyzed Formation of a Glutathione-Conjugated Spiro-azetidine without Prior Bioactivation Li XQ, Grönberg G, Bangur EH, Hayes MA, Catagnoli Jr. N, Weidolf L Drug Metabolism Disposition 47:1247–1256, 2019
2 Biotransformation of Myricetin: A Novel Metabolic Pathway to Produce Aminated Products in Mice Zhang S, Wang R, Zhao Y, Tareq FS, Sang FS Molecular Nutrition and Food Research 63(14):1900203, 2019
3 The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics Di L Current Drug Metabolism 20:91–102, 2019
4 Biocatalytic Reversal of Advanced Glycation End Product Modification Kim NY, Goddard TN, Sohn S, Spiegel DA, Crawford JM ChemBioChem 20:2402–2410, 2019
5 Molecular basis for the P450-catalyzed C–N bond formation in indolactam biosynthesis He F, Mori T, Morita I, Nakamura H, Alblova M, Hoshino S, Awakawa T, Abe I Nature Chemical Biology 15:1206–1213, 2019
6 Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans Podoll T, Pearson PG, Evarts J, Ingallinera T, Bibikova E, Sun H, Gohdes M, Cardinal K, Sanghvi M, Slatter JG Drug Metabolism Disposition 47:145–154, 2019
7 Catalytic cleavage of disulfide bonds in small molecules and linkers of antibody- drug conjugates Zhang D, Fourie-O’Donohue A, Dragovich PS, Pillow TH, Sadowsky JD, Kozak KR, Cass RT, Liu L, Deng Y, Liu Y, Hop CECA, Khojasteh SC Drug Metabolism Disposition 47(10):1156–1163, 2019
Bioactivation and Safety
8 Metabolic Activation of Tofacitinib Mediated by Myeloperoxidase in Vitro Guo Y, Jia Y, Han L, Zhao Y, Li W, Zhang Z, Peng Y, Zheng J Chemical Research in Toxicology 32:2459–2465, 2019
9 Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in Vivo Tailor A, Waddington J, Hamlett J, Maggs J, Kafu L, Farrell J, Dear G, Whitaker P, Naisbitt D, Park K, Meng X Chemical Research in Toxicology 32(10):2095–2106, 2019
10 Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model Ji C, Guha M, Zhu X, Whritenour J, Hemkens M, Tse S, Walker G, Evans E, Khan N, Finkelstein M, Callegari E, Obach R Chemical Research in Toxicology 32:2095–2106, 2019
11 Structure-activity Relationships of CYP4B1 Bioactivation of 4-ipomeanol Congeners: Direct Correlation Between Cytotoxicity and Trapped Reactive Intermediates. Kowalski JP, McDonald MG, Whittington D, Guttman M, Scian M, Girhard M, Hanenberg H, Wiek C, Rettie AE Chemical Research in Toxicology 32:2488–2498, 2019
12 A Metabolomic Perspective of Pazopanib-induced Acute Hepatotoxicity in Mice. Wang YK, Yang XN, Liang WQ, Xiao Y, Zhao Q, Xiao, Gonzalez FJ, Li F Xenobiotica 49(6):655–670, 2019
13 Rotenone Increases Isoniazid Toxicity but Does Not Cause Significant Liver Injury: Implications for the Hypothesis that Inhibition of the Mitochondrial Electron Transport Chain Is a Common Mechanism of Idiosyncratic Drug-Induced Liver Injury Cho T, Wang X, Uetrecht J Chemical Research in Toxicology 32:1423–1431, 2019
14 Mechanism of Idiosyncratic Drug-Induced Liver Injury Quantitative Evaluation of Reactivity and Toxicity of Acyl Glucuronides by [35S]-Cysteine Trapping Harada H, Toyoda Y, Abe Y, Endo T, Takeda H Chemical Research in Toxicology 32:1955–1964, 2019